产品封面图

pMetLuc2-Control载体

收藏
  • ¥2600
  • ZYbscience
  • 中国/美国
  • ZY
  • 2025年07月11日
    avatar
  • 企业认证

    点击 QQ 联系

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件

      -20℃低温保存

    • 保质期

      三年

    • 英文名

      pMetLuc2-Control

    • 库存

      20

    • 供应商

      泽叶生物

    载体基本信息

    出品公司: ZYbscience
    载体名称: pMetLuc2-Control
    质粒类型: 慢病毒载体;无启动子载体;荧光素酶报告载体
    高拷贝/低拷贝: 高拷贝
    克隆方法: 限制性内切酶,多克隆位点
    启动子: CMV
    载体大小: 4784 bp
    5' 测序引物及序列: CMV Forward: CGCAAATGGGCGGTAGGCGTG
    3' 测序引物及序列: --
    载体标签: --
    载体抗性: 卡那霉素
    筛选标记: 新霉素(Neomycin
    克隆菌株: DH5alpha等
    宿主细胞(系): 常规细胞系(293、CV-1、CHO等)
    备注: pMetLuc2-Control组成型表达荧光素酶MetLuc,作为pMetLuc2-Reporter载体的阳性对照;
    MetLuc是已知最小分子量的荧光素酶;
    荧光素酶报告基因可以用来定性定量分析启动子及其它顺式转录元件的活性。
    产品目录号: ZY631729
    稳定性: 瞬表达 或 稳表达
    组成型/诱导型: 组成型
    病毒/非病毒: 非病毒

    载体质粒图谱和多克隆位点信息

    pMetLuc2-Control载体图谱



    pMetLuc2-Control 载体特征

    载体简介

    pMetLuc2-Control载体描述
    
    The pMetLuc2-Control vector encodes a sequence-optimized, secreted luciferase from the marine copepod Metridia longa. The 24 kDa Metridia luciferase (MetLuc) contains a 17 amino acid, N-terminal signal peptide that allows the protein to be efficiently secreted into the cell culture medium (1), making it easy to detect without cell lysis.Expression of MetLuc is driven by the constitutively active cytomegalovirus immediate early promoter (PCMV IE). SV40 polyadenylation signals downstream of the MetLuc gene direct proper processing of the 3' end of the MetLuc mRNA. The vector backbone contains an SV40 origin for replication in mammalian cells expressing the SV40 large T antigen, a pUC origin of replication for propagation in E. coli, and an f1 origin for single-stranded DNA production. A neomycin-resistance cassette (Neor) allows stably transfected eukaryotic cells to be selected using G418. This cassette consists of the SV40 early promoter, the Tn5 kanamycin/neomycin resistance gene, and polyadenylation signals from the herpes simplex virus thymidine kinase (HSV TK) gene. The vector also contains a synthetic transcription blocker (TB), composed of adjacent polyadenylation and transcription pause sites, that reduces background readthrough transcription (2). A bacterial promoter (PKanr) upstream of the cassette allows kanamycin resistance in E. coli.
    
    The pMetLuc2-Control vector can be used as a positive control for the constitutive expression and secretion of MetLuc in experiments using the pMetLuc2-Reporter vector. pMetLuc2-Control can also be used to monitor the inhibitory effect of drugs, such as Brefeldin A, on protein secretion.
    The pMetLuc2-Control Vector can be transfected into mammalian cells using any standard transfection method. Stable transfectants can be selected using G418 when required (3). The presence of MetLuc in the cell culture medium can be easily detected by adding luciferase substrate to a small aliquot of the medium and analyzing the sample with a luminometer.
    
    Propagation in E. coli
     Suitable host strains: DH5α, HB101, and other general purpose strains. Single-stranded DNA production
    requires a host containing an F plasmid such as JM109 or XL1-Blue.
     Selectable marker: plasmid confers resistance to kanamycin (50 μg/ml) in E. coli hosts.
     E. coli replication origin: pUC
     Plasmid incompatibility group: pMB1/Col E1
    
    Note: The attached sequence file has been compiled from information in the sequence databases, published literature, and other sources, together with partial sequences obtained by Clontech. This vector has not been completely sequenced.
    
    References
    1. Markova, S.V. et al. (2004) J. Bio. Chem. 279(5):3212-3217.
    2. Eggermont, J. & Proudfoot, N. (1993) EMBO J. 12(6):2539–2548.
    3. Gorman, C. (1985) DNA cloning: A Practical Approach, Vol. II. Ed. D. M. Glover. (IRL Press Oxford, U.K.), pp. 143-190.
    
    

    载体序列

    LOCUS       pMetLuc2-Control   4781 bp    DNA   circular             8-NOV-2009
    COMMENT     Created by Clontech Laboratories Inc. http://www.clontech.com
    COMMENT     Cat. No. 631735,631731,631743,631744,631732,631742,631729,631745,631730
    FEATURES             Location/Qualifiers
         CDS             2517..3311
                         /label=Kan(R)/Neo(R)
         promoter        1..589
                         /label=CMV\IE\Promoter
         CDS             628..1285
                         /label=Metridia\luciferase
         misc_feature    4569..4722
                         /label=Transcription\blocker
         polyA_signal    1440..1445
                         /label=SV40\early\poly\A\signal
         polyA_signal    1469..1474
                         /label=SV40\early\polyA\signal
         polyA_signal    3547..3552
                         /label=HSV\TK\polyA\signal
         polyA_signal    3560..3565
                         /label=HSV\TK\polyA\signal
         rep_origin      complement(1537..1992)
                         /label=f1\origin
         rep_origin      3896..4539
                         /label=pUC\origin
         rep_origin      2333..2471
                         /label=SV40\origin
         misc_feature    2388..2394
                         /label=SV40\early\Promoter
         promoter        2054..2082
                         /label=Kan(R)\Promoter
    BASE COUNT     1171 a      1268 c      1253 g      1089 t 
    ORIGIN
            1 tagttattaa tagtaatcaa ttacggggtc attagttcat agcccatata tggagttccg 
           61 cgttacataa cttacggtaa atggcccgcc tggctgaccg cccaacgacc cccgcccatt 
          121 gacgtcaata atgacgtatg ttcccatagt aacgccaata gggactttcc attgacgtca 
          181 atgggtggag tatttacggt aaactgccca cttggcagta catcaagtgt atcatatgcc 
          241 aagtacgccc cctattgacg tcaatgacgg taaatggccc gcctggcatt atgcccagta 
          301 catgacctta tgggactttc ctacttggca gtacatctac gtattagtca tcgctattac 
          361 catggtgatg cggttttggc agtacatcaa tgggcgtgga tagcggtttg actcacgggg 
          421 atttccaagt ctccacccca ttgacgtcaa tgggagtttg ttttggcacc aaaatcaacg 
          481 ggactttcca aaatgtcgta acaactccgc cccattgacg caaatgggcg gtaggcgtgt 
          541 acggtgggag gtctatataa gcagagctgg tttagtgaac cgtcagatcc gctagcgcta 
          601 ccggactcag atccaccggt cgccaccatg gacatcaagg tggtgttcac cctggtgttc 
          661 agcgccctgg tgcaggccaa gagcaccgag ttcgacccca acatcgacat cgtgggcctg 
          721 gaaggcaagt tcggcatcac caacctggaa accgacctgt tcaccatctg ggagaccatg 
          781 gaagtgatga tcaaggccga catcgccgac accgaccggg ccagcaactt cgtggccacc 
          841 gagaccgacg ccaaccgggg caagatgccc ggcaagaagc tgcccctggc cgtcatcatg 
          901 gaaatggaag ccaacgcctt caaggccggc tgcacccggg gctgcctgat ctgcctgagc 
          961 aagatcaagt gcaccgccaa gatgaaggtg tacatccccg gcaggtgcca cgactacggc 
         1021 ggcgacaaga aaaccggcca ggccggcatc gtgggcgcca tcgtggacat ccccgagatc 
         1081 agcggcttca aagaaatggc ccccatggaa cagttcatcg cccaggtgga cagatgcgcc 
         1141 agctgcacca ccggctgcct gaagggcctg gccaacgtga agtgcagcga gctgctgaag 
         1201 aagtggctgc ccgaccgctg cgccagcttc gccgacaaga tccagaaaga ggtgcacaac 
         1261 atcaagggca tggccggcga caggtgagcg gccgcgactc tagatcataa tcagccatac 
         1321 cacatttgta gaggttttac ttgctttaaa aaacctccca cacctccccc tgaacctgaa 
         1381 acataaaatg aatgcaattg ttgttgttaa cttgtttatt gcagcttata atggttacaa 
         1441 ataaagcaat agcatcacaa atttcacaaa taaagcattt ttttcactgc attctagttg 
         1501 tggtttgtcc aaactcatca atgtatctta aggcgtaaat tgtaagcgtt aatattttgt 
         1561 taaaattcgc gttaaatttt tgttaaatca gctcattttt taaccaatag gccgaaatcg 
         1621 gcaaaatccc ttataaatca aaagaataga ccgagatagg gttgagtgtt gttccagttt 
         1681 ggaacaagag tccactatta aagaacgtgg actccaacgt caaagggcga aaaaccgtct 
         1741 atcagggcga tggcccacta cgtgaaccat caccctaatc aagttttttg gggtcgaggt 
         1801 gccgtaaagc actaaatcgg aaccctaaag ggagcccccg atttagagct tgacggggaa 
         1861 agccggcgaa cgtggcgaga aaggaaggga agaaagcgaa aggagcgggc gctagggcgc 
         1921 tggcaagtgt agcggtcacg ctgcgcgtaa ccaccacacc cgccgcgctt aatgcgccgc 
         1981 tacagggcgc gtcaggtggc acttttcggg gaaatgtgcg cggaacccct atttgtttat 
         2041 ttttctaaat acattcaaat atgtatccgc tcatgagaca ataaccctga taaatgcttc 
         2101 aataatattg aaaaaggaag agtcctgagg cggaaagaac cagctgtgga atgtgtgtca 
         2161 gttagggtgt ggaaagtccc caggctcccc agcaggcaga agtatgcaaa gcatgcatct 
         2221 caattagtca gcaaccaggt gtggaaagtc cccaggctcc ccagcaggca gaagtatgca 
         2281 aagcatgcat ctcaattagt cagcaaccat agtcccgccc ctaactccgc ccatcccgcc 
         2341 cctaactccg cccagttccg cccattctcc gccccatggc tgactaattt tttttattta 
         2401 tgcagaggcc gaggccgcct cggcctctga gctattccag aagtagtgag gaggcttttt 
         2461 tggaggccta ggcttttgca aagatcgatc aagagacagg atgaggatcg tttcgcatga 
         2521 ttgaacaaga tggattgcac gcaggttctc cggccgcttg ggtggagagg ctattcggct 
         2581 atgactgggc acaacagaca atcggctgct ctgatgccgc cgtgttccgg ctgtcagcgc 
         2641 aggggcgccc ggttcttttt gtcaagaccg acctgtccgg tgccctgaat gaactgcaag 
         2701 acgaggcagc gcggctatcg tggctggcca cgacgggcgt tccttgcgca gctgtgctcg 
         2761 acgttgtcac tgaagcggga agggactggc tgctattggg cgaagtgccg gggcaggatc 
         2821 tcctgtcatc tcaccttgct cctgccgaga aagtatccat catggctgat gcaatgcggc 
         2881 ggctgcatac gcttgatccg gctacctgcc cattcgacca ccaagcgaaa catcgcatcg 
         2941 agcgagcacg tactcggatg gaagccggtc ttgtcgatca ggatgatctg gacgaagagc 
         3001 atcaggggct cgcgccagcc gaactgttcg ccaggctcaa ggcgagcatg cccgacggcg 
         3061 aggatctcgt cgtgacccat ggcgatgcct gcttgccgaa tatcatggtg gaaaatggcc 
         3121 gcttttctgg attcatcgac tgtggccggc tgggtgtggc ggaccgctat caggacatag 
         3181 cgttggctac ccgtgatatt gctgaagagc ttggcggcga atgggctgac cgcttcctcg 
         3241 tgctttacgg tatcgccgct cccgattcgc agcgcatcgc cttctatcgc cttcttgacg 
         3301 agttcttctg agcgggactc tggggttcga aatgaccgac caagcgacgc ccaacctgcc 
         3361 atcacgagat ttcgattcca ccgccgcctt ctatgaaagg ttgggcttcg gaatcgtttt 
         3421 ccgggacgcc ggctggatga tcctccagcg cggggatctc atgctggagt tcttcgccca 
         3481 ccctaggggg aggctaactg aaacacggaa ggagacaata ccggaaggaa cccgcgctat 
         3541 gacggcaata aaaagacaga ataaaacgca cggtgttggg tcgtttgttc ataaacgcgg 
         3601 ggttcggtcc cagggctggc actctgtcga taccccaccg agaccccatt ggggccaata 
         3661 cgcccgcgtt tcttcctttt ccccacccca ccccccaagt tcgggtgaag gcccagggct 
         3721 cgcagccaac gtcggggcgg caggccctgc catagcctca ggttactcat atatacttta 
         3781 gattgattta aaacttcatt tttaatttaa aaggatctag gtgaagatcc tttttgataa 
         3841 tctcatgacc aaaatccctt aacgtgagtt ttcgttccac tgagcgtcag accccgtaga 
         3901 aaagatcaaa ggatcttctt gagatccttt ttttctgcgc gtaatctgct gcttgcaaac 
         3961 aaaaaaacca ccgctaccag cggtggtttg tttgccggat caagagctac caactctttt 
         4021 tccgaaggta actggcttca gcagagcgca gataccaaat actgttcttc tagtgtagcc 
         4081 gtagttaggc caccacttca agaactctgt agcaccgcct acatacctcg ctctgctaat 
         4141 cctgttacca gtggctgctg ccagtggcga taagtcgtgt cttaccgggt tggactcaag 
         4201 acgatagtta ccggataagg cgcagcggtc gggctgaacg gggggttcgt gcacacagcc 
         4261 cagcttggag cgaacgacct acaccgaact gagataccta cagcgtgagc tatgagaaag 
         4321 cgccacgctt cccgaaggga gaaaggcgga caggtatccg gtaagcggca gggtcggaac 
         4381 aggagagcgc acgagggagc ttccaggggg aaacgcctgg tatctttata gtcctgtcgg 
         4441 gtttcgccac ctctgacttg agcgtcgatt tttgtgatgc tcgtcagggg ggcggagcct 
         4501 atggaaaaac gccagcaacg cggccttttt acggttcctg gccttttgct ggccttttgc 
         4561 tcacatgtaa taaaatatct ttattttcat tacatctgtg tgttggtttt ttgtgtgaat 
         4621 cgatagtact aacatacgct ctccatcaaa acaaaacgaa acaaaacaaa ctagcaaaat 
         4681 aggctgtccc cagtgcaagt gcaggtgcca gaacatttct ctacatgttc tttcctgcgt 
         4741 tatcccctga ttctgtggat aaccgtatta ccgccatgca t 
    //

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • QIAgenes 预制蛋白表达载体

      E. coli • 预制蛋白表达载体,专门针对35,000个人类基因所设计 • 合成全长、序列优化且经过验证的cDNA,cDNA免费克隆到表达载体,确保在E.coli体内体外系统高效表达蛋白 • 整套解决方案,提供QIAgenes Expression construct E.coli, Positive Control, Anti-His Antibody和Ni-NTA Spin column表达载体结构 • 含有T7启动子,可直接在BL21(DE3)等菌株或利用无细胞系统进行

    • 腺病毒 | 高效基因载体工具

      :lncRNA FR215775 Regulates Th2 Differentiation in Murine Allergic Rhinitis 期刊:Journal of Immunology Research 影响因子:4.493 研究领域:过敏性鼻炎(AR) 主要应用:构建lncRNA FR215775的干扰腺病毒载体(sh-FR215775-Ads)和对照腺病毒载体(sh-control),感染AR小鼠模型分离出的原代CD4+T细胞,以及通过尾静脉注射到AR小鼠体内。通过体内外实验表明

    • 双荧光素酶报告基因测试

      摩尔)的对照报告基因酶(图3B),并且这两个酶的特异活力相似。 图2 用双荧光素酶报告基因测试由萤火虫和Renilla荧光素酶产生的发光。CHO细胞(1×106 /60mm培养板)共转染pGL3Control和pRL SV40载体DNA.细胞用PBS洗涤后,加入400μl PLB制成裂解液。将20μl小量细胞裂解液和100μl荧光素酶测试试剂II(LARII)混合,萤火虫荧光素酶的活力立即用荧光照度仪检测(细线示踪)。100μl Stop &GloTM 试剂加入到荧光照度仪管中,湮灭萤火

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥2595
    上海泽叶生物科技有限公司
    2025年07月11日询价
    ¥1000
    上海信裕生物科技有限公司
    2025年07月10日询价
    ¥1000
    上海再康生物科技有限公司
    2025年11月21日询价
    ¥800
    上海沪震实业有限公司
    2025年07月13日询价
    ¥750
    上海盖宁生物科技有限公司
    2025年12月23日询价
    pMetLuc2-Control载体
    ¥2600